141P Chemotherapy with or without immunotherapy or bevacizumab for EGFR-mutated lung cancer after progression on osimertinib M. White,J.W. Neal,R.M. Gardner,K.M. Cunanan,M. Das, S.K. Padda,K. Ramchandran,T.T. Chen,H. WakeleeJournal of Thoracic Oncology（2021）引用 3|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
